Author:
Liu Qifeng,Xu Yue,Lv Xueqi,Guo Congcong,Zhu Haibo,Yang Liu,Wang Yinghong
Reference71 articles.
1. Obesity and dyslipidemia;Vekic;Metabolism,2018
2. G. A. Roth, G. A. Mensah, C. O. Johnson, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 Study, J. Am. Coll. Cardiol. 76 (2020) 2982–3021. doi:https://doi.org/10.1016/j.jacc.2020.11.010.
3. Lobal Burden of Disease Collaborative Network. Global burden of disease study 2019 (GBD 2019) Reference Life Table. 2021. doi:https://doi.org/10.6069/1D4Y-YQ37.
4. Metabolic syndrome, dyslipidemia and regulation of lipoprotein metabolism;Iqbal;Curr. Diabetes Rev.,2017
5. Lipid metabolism and emerging targets for lipid-lowering therapy;Gaudet;Can. J. Cardiol.,2017